Nektar Therapeutics
NKTR
#5987
Rank
S$1.43 B
Marketcap
S$42.02
Share price
-5.46%
Change (1 day)
-46.49%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): S-$8.63

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$8.65. In 2025 the company made an earnings per share (EPS) of S-$13.17 a decrease over its 2024 EPS that were of S-$11.44.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$8.63-34.5%
2025S-$13.1715.12%
2024S-$11.44-59.54%
2023S-$28.28-25.89%
2022S-$38.16-31.12%
2021S-$55.3914.86%
2020S-$48.23-1.19%
2019S-$48.81-163.96%
2018S$76.31-725.4%
2017S-$12.20-42.73%
2016S-$21.3183.33%
2015S-$11.6239.53%
2014S-$8.33-69.29%
2013S-$27.12-6.67%
2012S-$29.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.63-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.92-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.44-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$1.82-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.19-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.77-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland